Q3 2024 Holdings
Filed 2024-11-13 | 26 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| QXO Inc(QXO) | COM NEW | 82846H405 | $406.1M | 25,750,781 | 29.5% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $318.4M | 555,000 | 23.1% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $235.2M | 1,065,000 | 17.1% |
| Liberty Broadband Corp(LBRDK) | COM SER C | 530307305 | $154.2M | 1,994,510 | 11.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $33.2M | 731,960 | 2.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $29.5M | 54,428 | 2.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $28.4M | 190,072 | 2.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $24.9M | 1,782,267 | 1.8% |
| Springworks Therapeutics Inc | COM | 85205L107 | $20.9M | 650,852 | 1.5% |
| MoonLake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $19.6M | 388,835 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $16.7M | 133,535 | 1.2% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $16.1M | 557,762 | 1.2% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $14.1M | 574,378 | 1.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $13.9M | 905,384 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.5M | 256,449 | 1.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $11.5M | 1,626,146 | 0.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $7.3M | 433,471 | 0.5% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $6.7M | 961,251 | 0.5% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $5.7M | 707,404 | 0.4% |
| Swiftmerge Acquisition Corp | *W EXP 12/13/202 | G63836111 | $39.2K | 490,000 | 0.0% |
| Compass Digital Acquisition Corp(COMP) | *W EXP 09/29/202 | G2476C123 | $28.1K | 459,906 | 0.0% |
| Moneyhero Limited | *W EXP 09/13/202 | G6202B119 | $26.9K | 895,000 | 0.0% |
| Marblegate Acquisition Corp | *W EXP 08/31/202 | 56608A113 | $25.3K | 735,000 | 0.0% |
| Lakeshore Biopharma Co LTD | *W EXP 03/15/202 | G9845F117 | $24.2K | 489,999 | 0.0% |
| Calidi Biotherapeutics Inc | COM NEW | 320703309 | $14.2K | 12,500 | 0.0% |
| Calidi Biotherapeutics Inc | *W EXP 03/14/202 | 320703119 | $8.6K | 655,200 | 0.0% |